Burning Rock Biotech Limited provided revenue guidance for the year 2022. The company currently expect full year 2022 revenues to be approximately RMB 620 million (USD 97.3 million), implying a 22% growth over full year 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.72 USD | -10.00% | -9.99% | -22.58% |
Apr. 02 | Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Revenue $75.7M | MT |
Apr. 02 | Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Loss $-0.90 | MT |
1st Jan change | Capi. | |
---|---|---|
-22.58% | 84.35M | |
-18.11% | 8.02B | |
+33.79% | 3.51B | |
-29.02% | 2.97B | |
-7.71% | 2.48B | |
-14.30% | 2.23B | |
-16.38% | 1.76B | |
-22.17% | 1.44B | |
-39.69% | 1.25B | |
-11.20% | 1.11B |
- Stock Market
- Equities
- BNR Stock
- News Burning Rock Biotech Limited
- Burning Rock Biotech Limited Provides Revenue Guidance for the Year 2022